scholarly article | Q13442814 |
P2093 | author name string | Adnan Nasir | |
P2860 | cites work | Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy | Q21223673 |
The Genome of the African Trypanosome Trypanosoma brucei | Q22065798 | ||
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? | Q24652185 | ||
The Dalila effect: C57BL6 mice barber whiskers by plucking | Q28145078 | ||
In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR | Q28290077 | ||
Toxic potential of materials at the nanolevel | Q28295314 | ||
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin | Q28307179 | ||
Comparative genomics of trypanosomatid parasitic protozoa | Q29617953 | ||
Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop | Q33285010 | ||
Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction | Q33293584 | ||
Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake | Q33358882 | ||
Antiviral prophylaxis of smallpox | Q34323056 | ||
Viral infections in atopic dermatitis Pathogenic aspects and clinical management | Q35562168 | ||
Requirements for Th1-dependent immunity against infection with Leishmania major | Q35893834 | ||
The effect of particle design on cellular internalization pathways | Q36954579 | ||
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells | Q40179067 | ||
Dermatologic toxicity of nanoengineered materials | Q47905517 | ||
Sequences of two kinetoplast minicircle DNAs of Trypanosoma (Nannomonas) congolense | Q48342282 | ||
Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. | Q50610735 | ||
Expression of B7-1 by Pam 212 squamous cell carcinoma enhances tumor cell interactions with dendritic epidermal cells but does not affect in vivo tumor growth | Q56908091 | ||
Increasing incidence of eczema herpeticum: analysis of seventy-five cases | Q67990603 | ||
Transcutaneous immunization: a human vaccine delivery strategy using a patch | Q73252637 | ||
Characterization of the altered cutaneous reactivity of transgenic mice whose keratinocytes overexpress B7-1 | Q74475027 | ||
B7-1 overexpression by thymic epithelial cells results in transient and long-lasting effects on thymocytes and peripheral T helper cells but does not result in immunodeficiency | Q77928232 | ||
AIDS research. Did Merck's failed HIV vaccine cause harm? | Q79843419 | ||
Antigenic targeting of the human mannose receptor induces tumor immunity | Q80257353 | ||
Dose sparing with intradermal injection of influenza vaccine | Q80961566 | ||
Molluscum contagiosum in Greek children: a case series | Q81609087 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanotechnology | Q11468 |
P304 | page(s) | 1055-1059 | |
P577 | publication date | 2009-05-01 | |
P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
P1476 | title | Nanotechnology in vaccine development: a step forward | |
P478 | volume | 129 |
Q24170384 | Applications of nanotechnology in dermatology |
Q38074461 | Inspired by nature: fundamentals in nanotechnology design to overcome biological barriers. |
Q36925868 | Nanomaterials in the application of tumor vaccines: advantages and disadvantages |
Q38813137 | Plague Vaccines: Status and Future |
Q40425661 | Plasmid pVAX1-NH36 purification by membrane and bead perfusion chromatography |
Q41628326 | Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production |
Q43477258 | Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses |
Q37820669 | Towards a Chlamydia trachomatis vaccine: how close are we? |
Q39390000 | Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals |
Q38105343 | Viral vaccines for bony fish: past, present and future. |
Search more.